Society for Basic Urologic Research (SBUR) 2013 Fall Symposium

项目摘要 生殖泌尿系统发育异常和疾病困扰着老年男性、女性和儿科人群 每年花费美国约110亿美元的医疗费用。R13提案旨在支持25 实习生和初级研究者（研究生、住院医生、临床科学家/博士后实习生 和非终身教职人员）在泌尿生殖系统研究的最大承诺与旅行奖500美元， 基础泌尿外科研究学会（SBUR）年度研讨会。SBUR是一个科学家协会， 医学科学家，专门研究人体组织的正常和病理状况 泌尿生殖道（GU）。SBUR的目标是1）促进特殊的基础和翻译泌尿外科 研究，2）增加代表性不足的少数民族的参与，3）激励年轻人和建立 研究人员推进基础和转化泌尿学研究的前沿。为了解决这三个问题， 优先事项，研讨会的主题是“泌尿系疾病异质性-需要多学科 研究方法。“任何一种疾病都涉及多种组织类型、细胞类型和信号通路。 泌尿系统疾病的表现需要一个跨学科的方法，涉及系统生物学和 新兴技术的应用。该计划的设计与这些科学的优先事项， 以下全体会议：一）主机和疾病，扭转局面，二）重新思考我们的基础和临床 了解泌尿生殖系统疾病，III）翻译技术，IV）干细胞是泌尿系统组织的一部分 异质性和治疗解决方案，V）试图把它们放在一起，是什么让治疗干预 难以捉摸此外，研讨会的两个指定讲师将由一位杰出的 系统生物学家和小儿泌尿科医生。解决少数民族在大多数族裔中代表性不足的问题 在研究方面，我们建议根据科学成就专门向少数群体提供至少五个旅行奖。 妇女和少数民族已经超过30%的受邀发言人在目前的计划。那里 一直是一个协调一致的努力，选择发言人谁成功地采用了多学科研究 作为年轻和成熟的研究人员的榜样。强调协作科学将是 讲座的一部分和多个正式讨论。学员将在五次全体会议中的每一次会议上作专题介绍 作为从优秀摘要中挑选出来的口头报告。甄选旅行奖获得者， 特殊的实习生申请人将由摘要遴选委员会与 执行理事会确保男女在奖学金获得者和申请者中的有效代表性 少数民族人口不足。研讨会将提供一个论坛，网络，互动， 在专注于GU发展和疾病的研究人员之间建立新的合作， 追求基础泌尿学研究的多样性。

Project Summary Genitourinary developmental anomalies and diseases afflict aging men, women and the pediatric population costing the US approximately $11 Billion a year in healthcare costs. This R13 proposal seeks to support 25 trainees and junior investigators (Graduate Students, Residents, Clinician-Scientist / Post-Doctoral Trainees and non-tenured faculty) in genitourinary research of the greatest promise with travel awards of $500 each to the Society for Basic Urological Research (SBUR) annual symposium. The SBUR is a society of scientists and physician-scientists specializing in research on the normal and pathological conditions of tissues of the human genitourinary (GU) tract. The goals of the SBUR are to 1) promote exceptional basic and translational urologic research, 2) increase participation by under-represented minorities, and 3) inspire young and established investigators to advance the frontiers of basic and translational urologic research. To address these three priorities, the theme of the Symposium is "Urologic Disease Heterogeneity - Requiring Multidisciplinary Research Approaches." There are multiple tissue type, cell types, and signaling pathways involved in any one urologic disease manifestation requiring a cross-disciplinary approach that involves systems biology and application of emerging technologies. The program is designed with these scientific priorities having the following plenary sessions: I) Host and disease, turning the tables, II) Re-thinking our basic and clinical understanding of urogenital diseases, III) Translating technology, IV) Stem cells are part of the urologic tissue heterogeneity and therapeutic solutions, V) Trying to put it all together, what makes therapeutic intervention elusive? Additionally, the two named lectureships for the symposium will be presented by a preeminent systems biologist and pediatric urologist. To address the recognized underrepresentation of minorities in GU research, we propose to provide at least five travel awards specifically to minorities based on scientific merit. Women and minorities are already greater than 30% of the invited speakers within the current program. There has been a concerted effort to select speakers who have successfully adopted multidisciplinary research approaches as examples for young and established investigators. Highlighting collaborative science will be part of the lectures and multiple formal discussions. Trainees will be featured in each of five plenary sessions as selected oral presentations from meritorious abstracts. Selection of travel awardees to promising and exceptional trainee applicants will be determined by the Abstract Selection committee in consultation with the Executive Council to ensure effective representation of both genders in the awardees and applicants of Underrepresented Minority populations. The Symposium will provide a forum for networking, interaction, and establishing new collaborations between investigators focused in GU development and disease celebrating the diversity of basic urologic research pursued.